Ashutosh Wechalekar

19PUBLICATIONS
148CO-AUTHORS
AutoimmunityBioinformatic methods developmentRheumatology and arthritisEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

|Dec 07, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.

Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani

|Aug 12, 2025
Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in amyloidosis: systematic review and meta-analysis.

Javier Herrera-Flores, Robin W M Vernooij, Arjun K Ghosh

|Jan 25, 2023
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.

Giovanni Palladini, Stefan Schönland, Giampaolo Merlini

|Oct 13, 2022
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias.

Sofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve

|Aug 18, 2022
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group.

Andrea Havasi, Cihan Heybeli, Nelson Leung

Pageof 4

Frequent Collaborators

5 joint publications

Vaishali Sanchorawala

4 joint publications

Efstathios Kastritis

4 joint publications

Shaji Kumar

3 joint publications

Sriram Ravichandran